Request Locked Data

45 datasets found

Temporal Features: Quarterly

Filter Results

  • Locked Data M_2_6_1

    Number of individuals with OUD who received behavioral health treatment in inpatient settings (Medicaid)

  • Locked Data M_2_5_3

    Number of individuals who received naltrexone (combined injectable and oral) for treatment of OUD (Medicaid)

  • Locked Data M_2_6_5

    Number of individuals with OUD who received case management (Medicaid)

  • Locked Data M_2_5_1

    Number of individuals who received buprenorphine for treatment of OUD (outcome measure for HCS Hypothesis 3)

  • Locked Data M_2_7_2

    Number of individuals receiving methadone retained at least 180 days (Medicaid)

  • Locked Data M_2_5_5

    Number of individuals who received buprenorphine for treatment of OUD (Medicaid)

  • Locked Data M_2_5_4

    Number of individuals who received medication for the treatment of OUD (Medicaid)

  • Locked Data M_2_5_2

    Number of individuals who received methadone for treatment of OUD (Medicaid)

  • Locked Data M_2_17

    Number of opioid-related overdoses treated in the emergency department and captured by syndromic surveillance data

  • Locked Data M_2_19

    Number of individuals screened for substance use (alcohol, drug use) (Medicaid)

  • Locked Data M_2_18

    Number of individuals with new opioid prescriptions limited to a 7-day supply

  • Locked Data M_2_4

    Number of individuals with opioid dependence or abuse (Medicaid)

  • Locked Data M_2_13_c

    Number of individuals with a new high-dose opioid prescribing episode, defined as ?90 mg morphine milligram equivalent (MME) over 3 calendar months

  • Locked Data M_2_13_d

    Number of individuals with new overlapping opioid and benzodiazepine prescriptions for at least 30 days over 3 calendar months

  • Locked Data M_2_13_b

    Number of individuals starting a new opioid prescribing episode with extended-release or long-acting opioid formulation

  • Locked Data M_2_12_2

    Number of opioid-related emergency department visits with MOUD follow-up within 31 days (Medicaid)

  • Locked Data M_2_14_1

    Number of naloxone units distributed through community-based programs

  • Locked Data M_2_15_1

    Number of individuals with OUD who are screened for hepatitis C

  • Locked Data M_2_15_2

    Number of individuals with OUD who are diagnosed with hepatitis C

  • Locked Data M_2_15_3

    Number of individuals with OUD who are treated for hepatitis C